Biotech · Private company
AC Immune SA
Track this companyFree. Adds AC Immune SA to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ACI-24.060 at Dose A in Study Part 1aPhase 2 · Amyloid PlaqueClinicalTrials.gov · fetched Nov 12, 2026
- ACI-24.060 at Dose B in Study Part 1aPhase 2 · Amyloid PlaqueClinicalTrials.gov · fetched Nov 12, 2026
- ACI-24.060 at Dose C in Study Part 1aPhase 2 · Amyloid PlaqueClinicalTrials.gov · fetched Nov 12, 2026
- ACI-24.060 with an additional adjuvant at Dose D in Study Part 1bPhase 2 · Amyloid PlaqueClinicalTrials.gov · fetched Nov 12, 2026
- ACI-24 high dosePhase 1 · Down SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ACI-24 low dosePhase 1 · Down SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)PHASE1_PHASE2 · RECRUITING · started Jun 21, 2022ClinicalTrials.gov NCT05462106 · fetched Nov 12, 2026
- Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the BrainEARLY_PHASE1 · COMPLETED · started Dec 24, 2020ClinicalTrials.gov NCT06445465 · fetched Nov 12, 2026
- Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down SyndromePHASE1 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02738450 · fetched Nov 12, 2026